Embedding Lessons Learned from Past Portfolio Decisions into New Governance Embedding Lessons Learned from Past Portfolio Decisions into New Governance The pharmaceutical industry is characterized by uncertainty and risk, particularly in drug development. To navigate this complexity, companies must consider a structured approach to decision-making, especially during the Go/No-Go junctures in their product portfolios. This article discusses how embedding lessons learned from past portfolio decisions can enhance governance frameworks, focusing on the criteria for Go/No-Go decisions, risk management techniques, the role of advanced technologies, and the importance of effective communication with stakeholders. The Importance of Go/No-Go Decision Criteria in Pharma…